MARC details
000 -LEADER |
fixed length control field |
pam a22 i 4500 |
001 - CONTROL NUMBER |
control field |
AALScienceDirectebook000003 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
BD-DhAAL |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20191205133250.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr cnu|||unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
180730s2018 enk ob 001 0 eng d |
015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
National bibliography number |
GBB8C0857 |
Source |
bnb |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
018922633 |
Source |
Uk |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0128144246 |
|
International Standard Book Number |
9780128144244 |
|
Cancelled/invalid ISBN |
0128144238 |
|
Cancelled/invalid ISBN |
9780128144237 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1046633728 |
Canceled/invalid control number |
(OCoLC)1047806807 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
BD-DhAAL |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RS200 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
071000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Edition number |
23 |
245 00 - TITLE STATEMENT |
Title |
Dosage form design considerations. |
Number of part/section of a work |
Volume 1 / |
Statement of responsibility, etc |
edited by Rakesh K. Tekade. |
Medium |
[electronic resource] |
260 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
London, United Kingdom : |
Name of publisher, distributor, etc |
Elsevier, |
Date of publication, distribution, etc |
[2018] |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource. |
490 1# - SERIES STATEMENT |
Series statement |
Advances in pharmaceutical product development and research series |
500 ## - GENERAL NOTE |
General note |
<strong>Off-Campus Access:</strong> Athens ID and Password Required |
|
General note |
<strong>On-Campus Access:</strong> No User ID or Password Required |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Front Cover; Dosage Form Design Considerations; Copyright Page; Dedication; Contents; List of Contributors; About the Editor; 1 Preformulation in Drug Research and Pharmaceutical Product Development; 1.1 Introduction; 1.1.1 An Overview of Formulation Life Cycle and Management; 1.1.2 Need of Preformulation: First Stage of Formulation Development; 1.1.3 Major Hurdles Impeding Successful Product Development; 1.1.4 Role of Preformulation During Product Development; 1.2 Parameters of preformulation studies; 1.2.1 Solubility; 1.2.2 The Permeability of the Drug |
|
Formatted contents note |
1.2.3 Bulk Characterization: Physical, Analytical, and Physicochemical1.2.4 Inherent Properties: pH, pKa, Log P, Log D, and Intrinsic Dissolution; 1.2.5 Stability: The Solution, Solid State, & ICH Photostability; 1.2.6 Drug-Excipient Compatibility; 1.2.7 Particle Size and Distribution; 1.2.8 Thermal Properties; 1.2.9 Hygroscopicity; 1.2.10 Bulk Properties; 1.2.11 Mechanical Properties and Compatibility; 1.2.12 Crystallinity and Polymorphism; 1.3 Role of preformulation in drug discovery; 1.3.1 Material Properties in Lead Selection, High Throughput Preformulation Studies |
|
Formatted contents note |
1.3.2 "Drugability" of New Chemical Entities1.3.3 Tools to Assist in Lead Selection; 1.4 Role of preformulation in drug development; 1.4.1 Identification of Challenges During Formulation Development: Pre-Assumptions; 1.4.2 The Dosage Form Specific Studies; 1.5 Preformulation studies of proteins and peptides; 1.6 Preformulation in vaccine development: Critical views; 1.7 Preformulation studies of packaging components; 1.8 Preformulation in 21st century: technological advancements; 1.8.1 Computerization and Aid of Software in the Preformulation Studies |
|
Formatted contents note |
1.8.2 Artificial Neural Network Tool Used in the Factorial Design: An Optimization Approach1.9 Case studies on preformulation of dosage forms; 1.10 Pharmacokinetics and preformulation: Point to note; 1.11 Rules and regulations in preformulation studies: Role of regulatory bodies; 1.12 Future remarks and conclusion; Acknowledgment; Abbreviations; References; Further Reading; 2 Physicochemical Aspects to Be Considered in Pharmaceutical Product Development; 2.1 Introduction; 2.2 Physical Characteristics of Solid Substances Used in Pharmaceutical Product Development |
|
Formatted contents note |
2.2.1 Crystalline Solid-State Substances2.2.1.1 Polymorphism; 2.2.1.2 Hydrates; 2.2.1.3 Solvates; 2.2.1.4 Cocrystals; 2.2.2 Amorphous Solids; 2.2.3 Particle Size; 2.2.4 Wettability; 2.2.5 Hygroscopicity; 2.3 Chemical Characteristics to be Considered in Pharmaceutical Product Development; 2.3.1 Degradation Reactions of Drugs; 2.3.1.1 Hydrolysis; 2.3.1.2 Dehydration; 2.3.1.3 Oxidation; 2.3.1.4 Photochemical Degradation; 2.3.1.5 Isomerization; 2.3.1.6 Polymerization; 2.3.1.7 Other Reactions; 2.4 Solubility Aspects in Pharmaceutical Products Development; 2.4.1 Aqueous Solubility |
506 ## - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Electronic access restricted to authorized BRAC University faculty, staff and students |
520 ## - SUMMARY, ETC. |
Summary, etc |
Dosage Form Design Parameters, Volume I, examines the history and current state of the field within the pharmaceutical sciences, presenting key developments. Content includes drug development issues, the scale up of formulations, regulatory issues, intellectual property, solid state properties and polymorphism. Written by experts in the field, this volume in the Advances in Pharmaceutical Product Development and Research series deepens our understanding of dosage form design parameters. Chapters delve into a particular aspect of this fundamental field, covering principles, methodologies and the technologies employed by pharmaceutical scientists. In addition, the book contains a comprehensive examination suitable for researchers and advanced students working in pharmaceuticals, cosmetics, biotechnology and related industries. |
538 ## - SYSTEM DETAILS NOTE |
System details note |
Mode of access: Internet |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Drug delivery systems. |
9 (RLIN) |
37984 |
|
Topical term or geographic name as entry element |
Drug development. |
9 (RLIN) |
37985 |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Design. |
9 (RLIN) |
37986 |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Dosage forms. |
9 (RLIN) |
37987 |
|
Topical term or geographic name as entry element |
Drug delivery systems. |
Source of heading or term |
fast |
9 (RLIN) |
37984 |
|
Topical term or geographic name as entry element |
Drug development. |
Source of heading or term |
fast |
9 (RLIN) |
37985 |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Design. |
Source of heading or term |
fast |
9 (RLIN) |
37986 |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Dosage forms. |
Source of heading or term |
fast |
9 (RLIN) |
37987 |
|
Topical term or geographic name as entry element |
MEDICAL / Pharmacology. |
Source of heading or term |
bisacsh |
9 (RLIN) |
37988 |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
-- |
37989 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Tekade, Rakesh K., |
Relator term |
editor. |
9 (RLIN) |
37990 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Qualifying information |
Original |
International Standard Book Number |
0128144238 |
-- |
9780128144237 |
Record control number |
(OCoLC)1007038271 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Advances in pharmaceutical product development and research series. |
9 (RLIN) |
37991 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Public note |
Full text available on ScienceDirect |
Uniform Resource Identifier |
<a href="https://www.sciencedirect.com/science/book/9780128144237">https://www.sciencedirect.com/science/book/9780128144237</a> |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Item type |
E-Book |